Riskpilot← Back to searchSign inGet full accessBIOMEDIC AS
ASActiveOrg 926433059Claude Monets Alle 14, 1338 SandvikaWholesale of perfume and cosmetics · NACE 4645Est. 20210 employees
Revenue 2024
NOK 0
EBITDA margin
—
+42% vs 2023
Equity ratio
—
Financial strength
Net profit 2024
NOK -194K
-219% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -1K | +42% |
| Net profit | NOK -194K | -219% |
| Total assets | NOK 0 | -100% |
| Equity | NOK -471K | -70% |
| Employees | 0 | — |
Legal name
BIOMEDIC AS
Org number
926433059
Legal form
Aksjeselskap
NACE code
4645 · Wholesale of perfume and cosmetics
Founded
21. januar 2021
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Importør, salg av kosmetiske produkter, kursleverandør, produksjon av kosmetiske produkter, konsept og kjedeutvikler
Address
Claude Monets Alle 14, 1338 Sandvika
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 70 | 13 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 |
| EBITDA | −167 | −9 | −2 | −1 |
| Depreciation & amort. | −0 | −0 | −0 | −0 |
| EBIT | −167 | −9 | −2 | −1 |
| Net financials | −15 | −55 | −59 | −193 |
| Profit before tax | −182 | −63 | −61 | −194 |
| Tax | −0 | −0 | −0 | −0 |
| Net profit | −182 | −63 | −61 | −194 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 156 | 123 | 123 | 0 |
| Equity | −152 | −216 | −277 | −471 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 308 | 338 | 399 | 471 |
| Total debt | 308 | 338 | 399 | 471 |
EBITDA margin
-129000.0%
This company
15.8%
Market median
-816556% vs market
20212024
Equity ratio
-47080200.0%
This company
38.2%
Market median
-123246697% vs market
20212024
Return on equity
-19420500.0%
This company
18.4%
Market median
-105546296% vs market
20212024
Net profit margin
-19420500.0%
This company
8.1%
Market median
-239759359% vs market
20212024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212024
Debt / equity
1.00×
This company
0.62×
Market median
-61% vs market
20212024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Chairman | 2021 | |
| Chairman | 2025 | |
| Chairman | 2025 | |
| Board of Directors | 2023 | |
| Former (1) | ||
| Board of Directors | 2023 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 | |
| Company | 50% | 50% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
NYQUIST HOLDING AS
BIOMEDIC AS Board members of BIOMEDIC AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jakob Nyquist | Chairman | 0 companies |
| Geir Johansen | Chairman | 0 companies |
| Geir Raffner Johansen | Chairman | 0 companies |
| Lill-Anita Mendoza Nyquist | Board of Directors | 0 companies |
| Lill-Anita Nyquist | Board of Directors | 0 companies |